Enovis Quarterly Cash Flow Statement
NYSE: ENOVHealth CareIndustrial SpecialtiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Enovis free cash flow
In the quarter ended Jul 3, 2026, Enovis generated $75.0 million of operating cash flow and spent $43.9 million on capital expenditures. That left free cash flow of $31.1 million, a free-cash-flow margin of 5.3% of revenue. Free cash flow was up 815.8% from the prior year's $3.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
Enovis cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-07-03 | Q1 20262026-04-03 | Q4 20252025-12-31 | Q3 20252025-10-03 | Q2 20252025-07-04 | Q1 20252025-04-04 | Q4 20242024-12-31 | Q3 20242024-09-27 | Q2 20242024-06-28 | Q1 20242024-03-29 | Q4 20232023-12-31 | Q3 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1.04M | -8.45M | -520.45M | -570.91M | -36.55M | -55.70M | -703.20M | -31.26M | -18.51M | -71.84M | 3.08M | -2.84M |
| Net Income growth (YoY) | — | — | — | — | — | — | -22931.17% | — | — | — | — | — |
| Depreciation & Amortization | 71.03M | 73.36M | 1.13B | 74.38M | 71.55M | 71.44M | 717.44M | 71.23M | 65.76M | 73.40M | 56.62M | 55.46M |
| Stock-Based Compensation | 8.97M | 8.75M | 8.11M | 8.73M | 8.67M | 7.41M | 7.73M | 7.83M | 7.67M | 6.43M | 8.31M | 8.78M |
| Change in Working Capital | -20.49M | 468.00K | -1.04M | 32.12M | -19.86M | -35.08M | 39.54M | -13.94M | 5.21M | -34.81M | 1.13M | -20.76M |
| Operating Cash Flow | 75.03M | 23.95M | 88.54M | 82.58M | 47.77M | -1.60M | 88.33M | 53.56M | 7.77M | -36.16M | 68.42M | 31.01M |
| Capital Expenditures | -43.90M | -52.80M | -56.25M | -53.49M | -44.37M | -43.26M | -53.19M | -51.19M | -39.41M | -36.93M | -27.94M | -27.03M |
| Investing Cash Flow | -45.01M | -53.09M | -12.99M | -56.06M | -49.80M | -60.52M | -57.88M | -58.42M | -41.33M | -797.84M | -59.37M | -17.11M |
| Debt Repaid | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Financing Cash Flow | -50.56M | 26.02M | -72.92M | -36.91M | 6.23M | 51.19M | -20.08M | -148.00K | 2.51M | 864.54M | 2.79M | -13.70M |
| Net Change in Cash | -20.57M | -3.26M | 2.77M | -10.46M | 5.61M | -9.71M | 8.37M | -3.63M | -31.12M | 29.71M | 12.70M | -362.00K |
| Free Cash Flow | 31.14M | -28.85M | 32.29M | 29.09M | 3.40M | -44.86M | 35.14M | 2.37M | -31.63M | -73.08M | 40.47M | 3.98M |
This table shows 12 quarterly periods of Enovis's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ENOV's reporting calendar. What is a cash flow statement?